Literature DB >> 153232

Rate of drug metabolism in man measured by 14CO2-breath analysis.

R Platzer, R L Galeazzi, G Karlaganis, J Bircher.   

Abstract

Exhalation of 14CO2 in breath has been used to assess the rate of hepatic demethylation of (14C-dimethyl)aminopyrine, but due to the complexity of aminopyrine metabolism the pharmacokinetics of the procedure are insufficiently understood. Therefore, studies were performed in five individuals after oral administration of (14C-methoxy)glycodiazine, a model substance with relatively simple kinetic properties. Plasma concentrations of the drug and urinary output of its metabolites measured by high pressure liquid chromatography were analysed by a two-compartment open model. The terminal disappearance of 14CO2 from breath was practically identical with the terminal disappearance of glycodiazine from plasma, which could be correlated with the plasma clearance of free glycodiazine. The mean transit time of 14C-atoms from plasma to breath was 3 h. These results contribute to the pharmacokinetic basis for use of 14C-demethylation breath tests. In particular, they are consistent with the hypothesis that 14CO2-breath analysis may be used to assess certain pharmacokinetic parameters of appropriately labelled test compounds. These parameters may not necessarily be a direct reflection of the rate of demethylation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153232     DOI: 10.1007/bf00560464

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.

Authors:  J G Wagner
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

2.  [On 2-benzolsulfonylamino-5 (beta-methoxyethoxy) pyrimidine (Glycodiazin). VII. On the mechanism of demethylation of Glycodiazin].

Authors:  E Gerhards
Journal:  Arzneimittelforschung       Date:  1968-06

3.  Kinetics of CO2-HCO3 minus in normal adult males.

Authors:  H S Winchell; H Stahelin; N Kusubov; B Slanger; M Fish; M Pollycove; J H Lawrence
Journal:  J Nucl Med       Date:  1970-12       Impact factor: 10.057

4.  Considerations in analysis of breath 14CO2 data.

Authors:  H S Winchell; K Wiley
Journal:  J Nucl Med       Date:  1970-12       Impact factor: 10.057

5.  [Simulation of the biodynamics of glycodiazine with the analog computer].

Authors:  J Riemann; H Röpke; E Gerhards; K H Kolb; H Gibian
Journal:  Arzneimittelforschung       Date:  1968-11

6.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.

Authors:  B H Lauterburg; J Bircher
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

7.  Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

Authors:  I Gikalov; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

8.  Aminopyrine demethylation measured by breath analysis in cirrhosis.

Authors:  J Bircher; A Küpfer; I Gikalov; R Preisig
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

9.  [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].

Authors:  E GERHARDS; H GIBIAN; K H KOLB
Journal:  Arzneimittelforschung       Date:  1964-05

10.  Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.

Authors:  G W Hepner; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

View more
  8 in total

Review 1.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

2.  A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.

Authors:  D P Thornhill; C Steffen; K J Netter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

3.  The [14C]-aminopyrine breath test. A comparison of different forms of analysis.

Authors:  D A Henry; G Sharpe; S Chaplain; S Cartwright; G Kitchingman; G D Bell; M J Langman
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

4.  Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi.

Authors:  L Putcha; D P Griffith; S Feldman
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Metabolically programmed iron chelators.

Authors:  Raymond J Bergeron; Neelam Bharti; James S McManis; Jan Wiegand
Journal:  Bioorg Med Chem       Date:  2015-06-29       Impact factor: 3.641

6.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20

7.  Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.

Authors:  H Wietholtz; M Voegelin; M J Arnaud; J Bircher; R Preisig
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 8.  Desferrithiocin: a search for clinically effective iron chelators.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti
Journal:  J Med Chem       Date:  2014-09-10       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.